ES2493069T3 - CYBP como marcador del cáncer de pulmón - Google Patents

CYBP como marcador del cáncer de pulmón Download PDF

Info

Publication number
ES2493069T3
ES2493069T3 ES10722044.4T ES10722044T ES2493069T3 ES 2493069 T3 ES2493069 T3 ES 2493069T3 ES 10722044 T ES10722044 T ES 10722044T ES 2493069 T3 ES2493069 T3 ES 2493069T3
Authority
ES
Spain
Prior art keywords
lung cancer
cybp
marker
sample
stage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10722044.4T
Other languages
English (en)
Inventor
Herbert Andres
Johann Karl
Julia Kloeckner
Markus Roessler
Michael Tacke
Michael Thierolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2493069T3 publication Critical patent/ES2493069T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)

Abstract

Un procedimiento para valorar el cáncer de pulmón, in vitro, el cual comprende la medición, en una muestra, de la concentración de a) CYBP, en una muestra de fluido corporal, b), de una forma opcional, de uno o más marcadores distintos, adicionales, del cáncer de pulmón, y c) la utilización de los resultados de la medición, en la etapa (a) y, opcionalmente, en la etapa (b), en la valoración del cáncer de pulmón, en donde, la detección de CYBP, es indicativa para cáncer de pulmón.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14

Claims (1)

  1. imagen1
ES10722044.4T 2009-05-15 2010-05-17 CYBP como marcador del cáncer de pulmón Active ES2493069T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09006609 2009-05-15
EP09006609 2009-05-15
PCT/EP2010/056730 WO2010130839A1 (en) 2009-05-15 2010-05-17 Cybp as a marker of lung cancer

Publications (1)

Publication Number Publication Date
ES2493069T3 true ES2493069T3 (es) 2014-09-11

Family

ID=40902073

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10722044.4T Active ES2493069T3 (es) 2009-05-15 2010-05-17 CYBP como marcador del cáncer de pulmón

Country Status (7)

Country Link
US (1) US8951738B2 (es)
EP (1) EP2430450B1 (es)
JP (1) JP5571171B2 (es)
CN (1) CN102439455B (es)
CA (1) CA2761873A1 (es)
ES (1) ES2493069T3 (es)
WO (1) WO2010130839A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140364326A1 (en) * 2011-01-28 2014-12-11 F. Hoffmann-La Roche Sa Combinatorial biomarkers for clinical applications in lung cancer patient management
CN103389375B (zh) * 2013-07-10 2015-11-04 横店集团家园化工有限公司 一种用于肺癌诊断的液相芯片试剂盒
JP6613490B2 (ja) 2016-02-19 2019-12-04 国立大学法人 宮崎大学 腺癌の検出方法
CN105891482B (zh) * 2016-03-29 2017-12-19 复旦大学附属中山医院 一种基于生物标志物谱针对中国农村人口肺结节人群的肺癌风险预测模型

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060240441A1 (en) * 2003-10-03 2006-10-26 Bayer Pharmaceuticals Corporation Gene expression profiles and methods of use
KR100664589B1 (ko) * 2004-12-28 2007-01-04 김현기 인간 암 억제 유전자, 이에 의해 코딩되는 단백질, 및이를 포함하는 발현 벡터
US20070178504A1 (en) * 2005-12-22 2007-08-02 Tracey Colpitts Methods and marker combinations for screening for predisposition to lung cancer
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
JP5079023B2 (ja) * 2007-03-23 2012-11-21 エフ．ホフマン−ラ ロシュ アーゲー 肺癌用マーカーとしてのａｐｅｘ
US10815517B2 (en) * 2009-04-28 2020-10-27 Roche Diagnostics Operations, Inc. Use of DPPIV/seprase as a marker for cancer

Also Published As

Publication number Publication date
WO2010130839A1 (en) 2010-11-18
US8951738B2 (en) 2015-02-10
JP5571171B2 (ja) 2014-08-13
CN102439455A (zh) 2012-05-02
WO2010130839A4 (en) 2011-01-06
CN102439455B (zh) 2015-01-07
JP2012526976A (ja) 2012-11-01
US20120196303A1 (en) 2012-08-02
EP2430450A1 (en) 2012-03-21
EP2430450B1 (en) 2014-07-16
HK1165204A1 (en) 2012-09-28
CA2761873A1 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
ES2656962T3 (es) Métodos para evaluar la receptividad del endometrio de una paciente
ES2570632T3 (es) Procedimiento de determinación del inhibidor de elastasa de leucocito in vitro del cáncer colorrectal
CL2016000883A1 (es) Compuestos macrocíclicos, inhibidores de antígeno prostático específico de membrana (psma); composición farmacéutica; complejo de metal; y su uso para preparar compuestos radiomarcados útiles para la formación de imágenes para diagnosticar y para el tratamiento de cáncer de próstata y/o metástasis de la misma.
PH12018550037A1 (en) Quencher containing water-soluble polymer-conjugated nanomaterial and use thereof
BR112014013082A2 (pt) método para detectar adutos nucleossomos
MX355020B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
MX2017008421A (es) Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga.
MX360236B (es) Uso de marcadores en el diagnostico y tratamiento de cancer de prostata.
MX2009006378A (es) Biomarcadores para cancer.
MX2013001042A (es) Biomarcadores de cancer pancreatico y usos de los mismos.
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
ATE554389T1 (de) Apex als marker für lungenkrebs
ES2437240B1 (es) Método de obtención de datos útiles para el diagnóstico, pronóstico y clasificación de los pacientes con enfermedad pulmonar obstructiva crónica (EPOC) y/o cáncer de pulmón
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
Leung et al. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies
ES2493069T3 (es) CYBP como marcador del cáncer de pulmón
MX2017005126A (es) Metodos y composiciones para el diagnostico y pronostico de lesion renal e insuficiencia renal.
AR087363A1 (es) Uso del anticuerpo i-3859 para la deteccion y diagnostico de los canceres
EP3159695A3 (en) Methods for diagnosing pancreatic cancer
EP3385717A3 (en) Methods of detecting prostate cancer
BR112015019567A2 (pt) marcadores associados com inibidores de wnt
SV2017005459A (es) Uso de los inhibidores de pan fgfr y método para identificación de pacientes con cáncer elegibles para el tratamiento con un inhibidor de pan fgfr
EP4270007A3 (en) Use of dna-transcription factor complexes for cancer detection
AR076113A1 (es) Metodo o sistema que usa biomarcadores para el seguimiento de un tratamiento
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms